Trisalus Life Sciences logo

Trisalus Life Sciences Share Price (NASDAQ: TLSI)

$5.18

0.07

(1.37%)

Last updated on

Check the interactive Trisalus Life Sciences Stock chart to analyse performance

Trisalus Life Sciences stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$5.02
    Today's High:$5.25

    Day's Volatility :4.38%

  • 52 Weeks Low:$3.42
    52 Weeks High:$5.88

    52 Weeks Volatility :41.84%

Trisalus Life Sciences Stock Returns

PeriodTrisalus Life Sciences IncIndex (Russel 2000)
3 Months
-0.58%
0.0%
6 Months
-8.32%
0.0%
1 Year
4.02%
0.0%
3 Years
-47.68%
-4.7%

Trisalus Life Sciences Inc Key Stats

Check Trisalus Life Sciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.11
Open
$5.02
Today's High
$5.25
Today's Low
$5.02
Market Capitalization
$254.8M
Today's Volume
$63.2K
52 Week High
$5.88
52 Week Low
$3.42
Revenue TTM
$36.0M
EBITDA
$-30.3M
Earnings Per Share (EPS)
$-1.15
Profit Margin
-86.61%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-496.21%

Stock Returns calculator for Trisalus Life Sciences Stock including INR - Dollar returns

The Trisalus Life Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Trisalus Life Sciences investment value today

Current value as on today

₹1,09,300

Returns

₹9,300

(+9.3%)

Returns from Trisalus Life Sciences Stock

₹4,016 (+4.02%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Trisalus Life Sciences Stock

-17%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Trisalus Life Sciences Stock from India on INDmoney has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Trisalus Life Sciences Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Trisalus Life Sciences(by analysts ranked 0 to 5 stars)

Trisalus Life Sciences Share Price Target

What analysts predicted

Upside of 118.39%

Target:

$11.31

Current:

$5.18

Trisalus Life Sciences share price target is $11.31, a slight Upside of 118.39% compared to current price of $5.18 as per analysts' prediction.

Trisalus Life Sciences Stock Insights

  • Price Movement

    In the last 7 days, TLSI stock has moved up by 2.6%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 7.34M → 11.21M (in $), with an average increase of 13.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -10.37M → -8.28M (in $), with an average increase of 25.2% per quarter
  • TLSI vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 30.3%
  • TLSI vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 211.3%
  • Price to Sales

    ForTLSI every $1 of sales, investors are willing to pay $4.2, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Trisalus Life Sciences Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$29.4M
↑ 58.99%
Net Income
$-33.2M
↓ 43.71%
Net Profit Margin
-112.92%
↑ 206.01%

Trisalus Life Sciences Technicals Summary

Sell

Neutral

Buy

Trisalus Life Sciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Trisalus Life Sciences Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Trisalus Life Sciences Inc logo
23.92%
-8.32%
4.02%
-47.68%
-50.76%
Medtronic Plc logo
3.87%
-1.59%
4.32%
4.82%
-13.69%
Edwards Lifesciences Corp. logo
2.55%
13.95%
18.33%
-9.73%
-5.31%
Boston Scientific Corp. logo
0.09%
0.6%
30.02%
157.38%
154.4%
Stryker Corporation logo
3.63%
-0.85%
8.87%
89.43%
97.71%
Abbott Laboratories logo
5.15%
-5.37%
15.72%
26.56%
24.53%

About Trisalus Life Sciences Inc

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers. It offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. The company was founded in 2009 and is headquartered in Westminster, Colorado.
Organization
Trisalus Life Sciences
Employees
110
CEO
Ms. Mary T. Szela B.S.N., M.B.A.
Industry
Miscellaneous

Key Management of Trisalus Life Sciences Inc

NameTitle
Ms. Mary T. Szela B.S.N., M.B.A.
CEO, President & Director
Ms. Jodi Devlin
Chief of Clinical Strategy & Operations
Mr. David B. Patience
Chief Financial Officer
Ms. Lori Ann Santamaria
Vice President of Operations
Ms. Jennifer L. Stevens J.D.
Chief Regulatory Officer
Dr. Richard B. Marshak M.B.A., MBA, VMD
Chief Commercial Officer
Dr. Bryan F. Cox Ph.D.
Chief of Research
Mr. James E. Young
Secretary & Treasurer

Important FAQs about investing in TLSI Stock from India :

What is Trisalus Life Sciences share price today?

Trisalus Life Sciences share price today is $5.18 as on at the close of the market. Trisalus Life Sciences share today touched a day high of $5.25 and a low of $5.02.

What is the 52 week high and 52 week low for Trisalus Life Sciences share?

Trisalus Life Sciences share touched a 52 week high of $5.88 and a 52 week low of $3.42. Trisalus Life Sciences stock price today i.e. is closed at $5.18, lower by 11.9% versus the 52 week high.

How to invest in Trisalus Life Sciences Stock (TLSI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Trisalus Life Sciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Trisalus Life Sciences Shares that will get you 0.2896 shares as per Trisalus Life Sciences share price of $5.18 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Trisalus Life Sciences Stock (TLSI) from India?

Indian investors can start investing in Trisalus Life Sciences (TLSI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Trisalus Life Sciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Trisalus Life Sciences share’s latest price of $5.18 as on August 30, 2025 at 1:29 am IST, you will get 1.9305 shares of Trisalus Life Sciences. Learn more about fractional shares .

What are the returns that Trisalus Life Sciences has given to Indian investors in the last 5 years?

Trisalus Life Sciences stock has given -50.76% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?